Virginia Retirement Systems’s Translate Bio, Inc. Common Stock TBIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-41,800
Closed -$1.15M 1123
2021
Q2
$1.15M Sell
41,800
-2,500
-6% -$49.1K 0.01% 593
2021
Q1
$731K Buy
44,300
+13,800
+45% +$314K 0.01% 773
2020
Q4
$562K Buy
+30,500
New +$546K 0.01% 813

Virginia Retirement Systems's TBIO Position: Q3 2021 in Review

Virginia Retirement Systems sold out of Translate Bio, Inc. Common Stock (TBIO) in Q3 2021, closing a stake of 41,800 shares — an estimated $1.15M sold.

Virginia Retirement Systems first reported a position in TBIO in Q4 2020 and held it in 3 quarters. The position peaked at $1.15M in Q2 2021. 0 funds tracked by Wall St. Rank hold TBIO as of Q3 2021.

  • Virginia Retirement Systems reported no remaining Translate Bio, Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
  • Virginia Retirement Systems sold 41,800 Translate Bio, Inc. Common Stock shares in Q3 2021, an estimated $1.15M.
  • Virginia Retirement Systems first reported a position in Translate Bio, Inc. Common Stock in Q4 2020 and held it in 3 quarters.
  • Virginia Retirement Systems's Translate Bio, Inc. Common Stock position peaked at $1.15M in Q2 2021.
  • 0 funds tracked by Wall St. Rank held Translate Bio, Inc. Common Stock as of Q3 2021.

Based on Virginia Retirement Systems's 13F filing for Q3 2021, filed 21 Oct 2021.